KPV is an orally active fragment of alpha-melanocyte stimulation hormone. It has potent 
anti-inflammatory, immune-modulatory, and antimicrobial properties. It is unique because 
its anti-inflammatory effects are associated with improved immunity and antimicrobial effects. KPV is a naturally occurring isomer that is acetylated and amidated, making it 
highly resistant to enzymatic degradation, dramatically increasing the half-life, bioavailability, and target tissue affinity and potency compared to standard KPV. 
It is effective against viruses, bacteria, and fungi, being more potent against Candida than 
Diflucan at 111000th the dose and is free of side effects associated with antifungals, antibiotics, and antiparasitics. Studies with inflammatory bowel disease and other 
maladies associated with the colon have shown promise as well. The tripeptide, KPV has significant antimicrobial properties and anti-inflammatory properties - especially in those with psoriasis. In people with psoriasis, KPV has shown to limit symptoms of the condition 
including itchiness, dryness, redness, peeling, and more. Due to its preserved anti­
inflammatory effect but lack of pigmentary action, the C-terminal 
tripeptide of a-MSH, KPV, has been delineated as an alternative for anti-inflammatory 
therapy. KPV has also been shown to support the mast cell system and treatment of MCAS (Mast Cell Activation Syndrome).